Role of the plasminogen activator and matrix metalloproteinase systems in epidermal growth factor- and scatter factor-stimulated invasion of carcinoma cells

Cancer Research

Volumn 58, Issue 22, 1998, Pages 5221-5230

  Rosenthal, Eben L ^a   Johnson, Timothy M ^a   Allen, Edward D ^a   Apel, Ingrid J ^a   Punturieri, Antonello ^a   Weiss, Stephen J ^a,b  

^a UNIVERSITY OF MICHIGAN COMPREHENSIVE CANCER CENTER   (United States)

^b Division of Surgical Oncology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGENASE; EPIDERMAL GROWTH FACTOR; MATRIX METALLOPROTEINASE; PLASMINOGEN ACTIVATOR; SCATTER FACTOR; STROMELYSIN;

ARTICLE; CANCER CELL CULTURE; CANCER INVASION; CARCINOGENESIS; CELL MOTILITY; HUMAN; HUMAN CELL; NORTHERN BLOTTING; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; SKIN CANCER; SQUAMOUS CELL CARCINOMA;

ANIMALS; CARCINOMA, SQUAMOUS CELL; CELL MOVEMENT; EPIDERMAL GROWTH FACTOR; HEPATOCYTE GROWTH FACTOR; HUMANS; METALLOENDOPEPTIDASES; NEOPLASM INVASIVENESS; RATS; RECEPTORS, CELL SURFACE; TUMOR CELLS, CULTURED; URINARY PLASMINOGEN ACTIVATOR;

EID: 0032533511     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (74)

1. Birchmeier, C., and Birchmeier, W. Molecular aspects of mesenchymal-epithelial interactions. Annu. Rev. Cell Biol., 9: 511-540, 1993.
2. Grandis, J. R., Zeng, Q., and Tweardy, D. J. Retinoic acid normalizes the increased gene transcription rate of TGF-α and EGFR in head and neck cancer cell lines. Nat. Med., 2: 237-240, 1996.
3. Jeffers, M., Rong, S., and Vande Woude, G. F. Enhanced tumorigenicity and invasion-metastasis by hepatocyte growth factor/scatter factor-met signalling in human cells concomitant with induction of the urokinase proteolysis network. Mol. Cell. Biol., 16: 1115-1125, 1996.
4. Matsumoto, K., Date, K., Ohmichi, H., and Nakamura, T. Hepatocyte growth factor in lung morphogenesis and tumor invasion: role as a mediator in epithelium-mesenchyme and tumor-stroma interactions. Cancer Chemother. Pharmacol., 38: S42-S47, 1996.
5. Rosen, E. M., Nigam, S. K., and Goldberg, L. D. Scatter factor and the c-Met receptor: a paradigm for mesenchymal/epithelial interaction. J. Cell Biol., 127: 1783-1787, 1994.
6. Chen, J. D., Kim, J. P., Zhang, K., Sarret, Y., Wynn, K. C., Kramer, R. H., and Woodley, D. T. Epidermal growth factor (EGF) promotes human keratinocyte locomotion on collagen by increasing the α2 integrin subunit. Exp. Cell Res., 209: 216-223, 1993.
7. Crepaldi, T., Gautreau, A., Comoglio, P. M., Louvard, D., and Arpin, M. Ezrin is an effector of hepatocyte growth factor-mediated migration and morphogenesis in epithelial cells. J. Cell Biol., 138: 423-434, 1997.
8. Fujii, K., Furukawa, F., and Matsuyoshi, N. Ligand activation of overexpressed epidermal growth factor receptor results in colony dissociation and disturbed E-cadherin function in HSC-1 human cutaneous squamous carcinoma cells. Exp. Cell Res., 223: 50-62, 1996.
9. 1 integrin expression. Exp. Cell Res., 216: 261-272, 1995.
10. FAK) and promotes migration and invasion by oral squamous cell carcinoma cells. J. Biol. Chem., 269: 31807-31813, 1994.
11. Shibamoto, S., Hayakawa, M., Takeuchi, K., Hori, T., Oku, N., Miyazawa, K., Kitamura, N., Takeichi, M., and Ito, F. Tyrosine phosphorylation of β-catenin and plakoglobin enhanced by hepatocyte growth factor and epidermal growth factor in human carcinoma cells. Cell Adhesion Comm., 1: 295-305, 1994.
12. Török, N., Urrutia, R., Nakamura, T., and McNiven, M. A. Up-regulation of molecular motor-encoding genes during hepatocyte growth factor-and epidermal growth factor-induced cell motility. J. Cell. Physiol., 167: 422-433, 1996.
13. Crawford, H. C., and Matrisian, L. M. Proteases and their inhibitors in invasion and metastasis: tumor and stromal expression of matrix metalloproteinases and their role in tumor progression. Invasion Metastasis, 14: 234-245, 1994.
14. Boyd, D. Examination of the effects of epidermal growth factor on the production of urokinase and the expression of the plasminogen activator receptor in a human colon cancer cell line. Cancer Res., 49: 2427-2432, 1989.
15. DeClerck, Y. A., and Laug, W. E. Plasminogen activators and their inhibitors: cooperation between matrix metalloproteinases and the plasminogen activator-plasmin system in tumor progression. Enzyme Protein, 49: 72-84, 1996.
16. Jensen, P. J., and Rodeck, U. Autocrine/paracrine regulation of keratinocyte urokinase plasminogen activator through the TGF-α/EGF receptor. J. Cell. Physiol., 155: 333-339, 1993.
17. Niedbala, M. J., and Sartorelli, A. C. Regulation by epidermal growth factor of human squamous cell carcinoma plasminogen activator-mediated proteolysis of extracellular matrix. Cancer Res., 49: 3302-3309, 1989.
18. Pepper, M.S., Matsumoto, K., Nakamura, T., Orci, L., and Montesano, R. Hepatocyte growth factor increases urokinase-type plasminogen activator (u-PA) and u-PA receptor expression in Madin-Darby canine kidney epithelial cells. J. Biol. Chem., 267: 20493-20496, 1992.
19. Busso, N., Masur, K. S., Lazega, D., Waxman, S., and Ossowski, L. Induction of cell migration by pro-urokinase binding to its receptor: possible mechanism for signal transduction in human epithelial cells. J. Cell Biol., 126: 259-270, 1994.
20. Kobayashi, H., Ohi, H., Sugimura, M., Shinohara, H., Fujii, T., and Terao, T. Inhibition of in vitro ovarian cancer cell invasion by modulation of urokinase-type plasminogen activator and cathepsin B. Cancer Res., 52: 3610-3614, 1992.
21. Shapiro, R. L., Duquette, J. G., Roses, D. F., Nunes, L., Harris, M. N., Kamino, H., Wilson, E. L., and Rifkin, D. B. Induction of primary cutaneous melanocytic neoplasms in urokinase-type plasminogen activator (uPA)-deficient and wild-type mice: cellular blue nevi invade but do not progress to malignant melanoma in uPA-deficient animals. Cancer Res., 50: 3597-3604, 1996.
22. Stahl, A., and Mueller, B. M. Binding of urokinase to its receptor promotes migration and invasion of human melanoma cells in vitro. Cancer Res., 54: 3066-3071, 1994.
23. Waltz, D. A., Natkin, L. R., Fujita, R. M., Wei, Y., and Chapman, H. A. Plasmin and plasminogen activator inhibitor type 1 promote cellular motility by regulating the interaction between the urokinase receptor and vitronectin. J. Clin. Investig., 100: 58-67, 1997.
24. 5-directed cell migration. J. Biol. Chem., 271: 29393-29399, 1996.
25. Maina, F., Casagranda, F., Audero, E., Simeone, A., Comoglio, P. M., Klein, R., and Ponzetto, C. Uncoupling of Grb2 from the Met receptor in vivo reveals complex roles in muscle development. Cell, 87: 531-542, 1996.
26. Miettinen, P. J., Berger, J. E., Meneses, J., Phung, Y., Pedersen, R. A., Werb, Z., and Derynck, R. Epithelial immaturity and multiorgan failure in mice lacking epidermal growth factor receptor. Nature (Lond.), 376: 337-341, 1995.
27. Threadgill, D. W., Dlugosz, A. A., Hansen, L. A., Tennenbaum, T., Lichti, U., Yee, D., Lamantia, C., Mourton, T., Herrup, K., Harris, R. C., Barnard, J. A., Yuspa, S. H., Coffey, R. J., and Magnuson, T. Targeted disruption of mouse EGF receptor: effect of genetic background on mutant phenotype. Science (Washington DC), 269: 230-238, 1995.
28. Bugge, T. H., Flick, M. J., Daugherty, C. C., and Degen, J. L. Plasminogen deficiency causes severe thrombosis but is compatible with development and reproduction. Genes Dev., 9: 794-807, 1995.
29. Bugge, T. H., Kombrinck, K. W., Flick, M. J., Daugherty, C. C., Danton, M. J. S., and Degen, J. L. Loss of fibrinogen rescues mice from the pleiotropic effects of plasmin-ogen deficiency. Cell, 87: 709-719, 1996.
30. Bugge, T. H., Suh, T. T., Flick, M. J., Daugherty, C. C., Romer, J., Solbert, H., Ellis, V., Dano, K., and Degen, J. L. The receptor for urokinase-type plasminogen activator is not essential for mouse development or fertility. J. Biol. Chem., 270: 16886-16894, 1995.
31. Carmeliet, P., and Collen, D. Gene targeting and gene transfer studies of the plasminogen/plasmin system: implications in thrombosis, hemostasis, neointima formation, and atherosclerosis. FASEB J., 9: 934-938, 1995.
32. Carmeliet, P., Schoonjans, L., Kieckens, L., Ream, B., Degen, J., Bronson, R., De Vos, R., van den Oord, J. J., Collen, D., and Mulligan, R. C. Physiological consequences of loss of plasminogen activator gene function in mice. Nature (Lond.), 368: 419-424, 1994.
33. Dewerchin, M., Van Nuffelen, A., Wallays, G., Bouche, A., Moons, L., Carmeliet, P., Mulligan, R. C., and Collen, D. Generation and characterization of urokinase receptor-deficient mice. J. Clin. Investig., 97: 870-878, 1996.
34. Botos, I., Scapozza, L., Zhang, D., Liotta, L. A., and Meyer, E. F. Batimastat, a potent matrix metalloproteinase inhibitor, exhibits an unexpected mode of binding. Proc. Natl. Acad. Sci. USA, 93: 2749-2754, 1996.
35. Montgomery, A. M. P., Mueller, B. M., Reisfeld, R. A., Taylor, S. M., and DeClerck, Y. A. Effect of tissue inhibitor of the matrix metalloproteinases-2 expression on the growth and spontaneous metastasis of a human melanoma cell line. Cancer Res., 54: 5467-5473, 1994.
36. Montgomery, A. M. P., DeClerck, Y. A., Langley, K. E., Reisfeld, R. A., and Mueller, B. M. Melanoma-mediated dissolution of extracellular matrix: contribution of urokinase-dependent and metalloproteinase-dependent proteolytic pathways. Cancer Res., 53: 693-700, 1993.
37. Birkedal-Hansen, H. Proteolytic remodeling of extracellular matrix. Curr. Opin. Cell Biol., 7: 728-735, 1995.
38. Cawston, T. E. Metalloproteinase inhibitors and the prevention of connective tissue breakdown. Pharmacol. Ther., 70: 163-182, 1996.
39. Pei, D., and Weiss, S. J. Furin-dependent intracellular activation of the human stromelysin-3 zymogen. Nature (Lond.), 375: 244-247, 1995.
40. Pei, D., and Weiss, S. J. Transmembrane-deletion mutants of the membrane-type matrix metalloproteinase-1 activate progelatinase A and express intrinsic matrix-degrading activity. J. Biol. Chem., 271: 9135-9140, 1996.
41. Boccaccio, C., Gaudino, G., Gambarotta, G., Galimi, F., and Comoglio, P. M. Hepatocyte growth factor (HGF) receptor expression is inducible and is part of the delayed-early response to HGF. J. Biol. Chem., 269: 12846-12851, 1994.
42. Block, G. D., Locker, J., Bowen, W. C., Petersen, B. E., Katyal, S., Strom, S. C., Riley, T., Howard, T. A., and Michalopoulos, G. K. Population expansion, clonal growth, and specific differentiation patterns in primary cultures of hepatocytes induced by HGF/SF, EGF and TGFα in a chemically defined (HGM) medium. J. Cell Biol., 132: 1133-1149, 1996.
43. Birkedal-Hansen, H. Catabolism and turnover of collagens: collagenases. Methods Enzymol., 144: 140-167, 1987.
44. r 72,000 type IV collagenase in normal and malignant human fibroblastoid cells. Cancer Res., 52: 4540-4544, 1992.
45. Seltzer, J. L., Lee, A. Y., Akers, K. T., Sudbeck, B., Soulhon, E. A., Wayner, E. A., and Eisen, A. Z. Activation of 72-kDa type IV collagenase/gelatinase by normal fibroblasts in collagen lattices is mediated by integrin receptors but is not related to lattice contraction. Exp. Cell Res., 213: 365-374, 1994.
46. Gilles, C., Polette, M., Seiki, M., Birembaut, P., and Thompson, E. W. Implication of collagen type I-induced membrane-type 1-matrix metalloproteinase expression and matrix metalloproteinase-2 activation in the metastatic progression of breast carcinoma. Lab. Investig., 76: 651-660, 1997.
47. Rong, S., Segal, S., Anver, M., Resau, J. H., and Vande Woude, G. F. Invasiveness and metastasis of NIH 3T3 cells induced by Met-hepatocyte growth factor/scatter factor autocrine stimulation. Proc. Natl. Acad. Sci. USA, 91: 4731-4735, 1994.
48. Dunsmore, S. E., Rubin, S. J., Kovacs, S. O., Chedid, M., Parks, W. C., and Welgus, H. G. Mechanisms of hepatocyte growth factor stimulation of keratinocyte metalloproteinase production. J. Biol. Chem., 271: 24576-24582, 1996.
49. r 95,000 type IV collagenase/gelatinase and interstitial fibroblast-type collagenase by rat mucosal keratinocytes. J. Biol. Chem., 268: 19143-19151, 1993.
50. Ochieng, J., Fridman, R., Nangia-Makker, P., Liotta, L. A., Stetler-Stevenson, W. G., and Raz, A. Galectin-3 is a novel substrate for human matrix metalloproteinases-2 and -9. Biochemistry, 33: 14109-14114, 1994.
51. Pilcher, B. K., Dumin, J. A., Sudbeck, B. D., Krane, S. M., Welgus, H. G., and Parks, W. C. The activity of collagenase-1 is required for keratinocyte migration on a type I collagen matrix. J. Cell Biol., 137: 1445-1457, 1997.
52. Ray, J. M., and Stetler-Stevenson, W. G. Gelatinase A activity directly modulates melanoma cell adhesion and spreading. EMBO J., 14: 908-917, 1995.
53. Bugge, T. H., Kombrinck, K. W., Xiao, Q., Holmback, K., Daugherty, C. C., Witte, D. P., and Degen, J. L. Growth and dissemination of Lewis lung carcinoma in plasminogen-deficient mice. Blood, 90: 4522-4531, 1997.
54. Turksen, K., Choi, Y., and Fuchs, E. Transforming growth factor α induces collagen degradation and cell migration in differentiating human epidermal raft cultures. Cell Regul., 2: 613-625, 1991.
55. Windsor, L. J., Grenett, H., Birkedal-Hansen, B., Bodden, M. K., Engler, J. A., and Birkedal-Hansen, H. Cell type-specific regulation of SL-1 and SL-2 genes. Induction of the SL-2 gene but not the SL-1 gene by human keratinocytes in response to cytokines and phorbol esters. J. Biol. Chem., 268: 17341-17347, 1993.
56. Turck, J., Pollock, A. S., Lee, L. K., Marti, H. P., and Lovett, D. H. Matrix metalloproteinase 2 (gelatinase A) regulates glomerular mesangial cell proliferation and differentiation. J. Biol. Chem., 271: 15074-15083, 1996.
57. Corcoran, M. L., and Stetler-Stevenson, W. G. Tissue inhibitor of metalloproteinase-2 stimulates fibroblast proliferation via a cAMP-dependent mechanism. J. Biol. Chem., 270: 13453-13459, 1995.
58. Murphy, A. N., Unsworth, E. J., and Stetler-Stevenson, W. G. Tissue inhibitor of metalloproteinases-2 inhibits bFGF-induced human microvascular endothelial cell proliferation. J. Cell. Physiol., 157: 351-358, 1993.
59. Basbaum, C. B., and Werb, Z. Focalized proteolysis: spatial and temporal regulation of extracellular matrix degradation at the cell surface. Curr. Opin. Cell Biol., 8: 731-738, 1996.
60. Black, R. A., Durie, F. H., and Otten-Evans, C. Relaxed specificity of matrix metalloproteinases (MMPs) and TIMP insensitivity of tumor necrosis factor-α (TNF-α) production suggest the major TNF-α converting enzyme is not an MMP. Biochem. Biophys. Res. Commun., 225: 400-405, 1996.
61. Moss, M. L., Jin, S. L. C., Milla, M. E., Burkhart, W., Carter, H. L., Chen, W-J., Clay, W. C., Didsbury, J. R., Hassler, D., Hoffman, C. R., Kost, T. A., Lambert, M. H., Leesnitzer, M. A., MeCauley, P., McGeehan, G., Mitchell, J., Moyer, M., Pahel, G., Rocque, W., Overton, L. K., Schoenen, F., Seaton, T., Su, J-S., Warner, J., Willard, D., and Becherer, J. D. Cloning of a disintegrin metalloproteinase that processes precursor tumour-necrosis factor-α. Nature (Lond.), 385: 733-736, 1997.
62. Ohuchi, E., Imai, K., Fujii, Y., Sato, H., Seiki, M., and Okada, Y. Membrane type 1 matrix metalloproteinase digests interstitial collagens and other extracellular matrix macromolecules. J. Biol. Chem., 272: 2446-2451, 1997.
63. Cao, J., Rehemtulla, A., Bahou, W., and Zucker, S. Membrane type matrix metalloproteinase 1 activates pro-gelatinase A without furin cleavage of the N-terminal domain. J. Biol. Chem., 271: 30174-30180, 1996.
64. Knäuper, V., Will, H., López-Otin, C., Smith, B., Atkinson, S. J., Stanton, H., Hembry, R. M., and Murphy, G. Cellular mechanisms for human procollagenase-3 (MMP-13) activation. J. Biol. Chem., 271: 17124-17131, 1996.
65. Tournier, J. M., Polette, M., Hinnrasky, J., Beck, J., Werb, Z., and Basbaum, C. Expression of gelatinase A, a mediator of extracellular matrix remodeling, by tracheal gland serous cells in culture and in vivo. J. Biol. Chem., 269: 25454-25464, 1994.
66. Aimes, R. T., and Quigley, J. P. Matrix metalloproteinase-2 is an interstitial collagenase. J. Biol. Chem., 270: 5872-5876, 1995.
67. Fridman, R., Toth, M., Pena, D., and Mobashery, S. Activation of progelatinase B (MMP-9) by gelatinase A (MMP-2). Cancer Res., 55: 2548-2555, 1995.
68. Hua, J., and Muschel, R. J. Inhibition of matrix metalloproteinase 9 expression by a ribozyme blocks metastasis in a rat sarcoma model system. Cancer Res., 56: 5279-5284, 1996.
69. Gray, S. T., Wilkins, R. J., and Yun, K. Interstitial collagenase gene expression in oral squamous cell carcinoma. Am. J. Pathol., 141: 301-306, 1992.
70. Kusukawa, J., Harada, H., Shima, L., Sasaguri, Y., Kameyama, T., and Morimatsu, M. The significance of epidermal growth factor receptor and matrix metalloproteinase-3 in squamous cell carcinoma of the oral cavity. Oral Oncol., Eur. J. Cancer, 32B: 217-221, 1996.
71. Yoshizaki, T., Sato, H., Maruyama, Y., Murono, S., Furukawa, M., Park, C-S., and Seiki, M. Increased expression of membrane type 1-matrix metalloproteinase in head and neck carcinoma. Cancer (Phila.), 79: 139-144, 1997.
72. Koop, S., Schmidt, E. E., MacDonald, I. C., Morris, V. L., Khokha, R., Grattan, M., Leone, J., Chambers, A. F., and Groom, A. C. Independence of metastatic ability and extravasation: metastatic ras-transformed and control fibroblasls extravasate equally well. Proc. Natl. Acad. Sci. USA, 93: 11080-11084, 1996.
73. Boonstra, J., Rijken, P., Humbel, B., Cremers, F., Verkeleij, A., and van Bergen en Henegouwen, P. The epidermal growth factor. Cell Biol. Int., 19: 413-430, 1995.
74. Park, M., Dean, M., Kaul, K., Braun, M. A., Gonda, M. A., and Vande Woude, G. Sequence of MET proto-oncogene cDNA has features characteristic of the tyrosine kinase family of growth-factor receptors. Proc. Natl. Acad. Sci. USA, 84: 6379-6383, 1987.